Can FIP Be Present Even When Test Results Are Unclear

Feline Infectious Peritonitis (FIP) challenges the most experienced veterinarians and cat owners alike. Caused by a mutation of feline coronavirus, FIP is often fatal and can present with complex symptoms and diagnostic ambiguities. One of the most confounding aspects in the management and identification of FIP is the occurrence of ambiguous test results. Can FIP be present even when test findings are inconclusive? Understanding the nature of FIP, the limits of diagnostic methods, and the subtleties of clinical presentation is crucial for anyone advocating for feline health.

Understanding FIP: A Diagnostic Puzzle

FIP arises from a mutated form of feline coronavirus that targets the immune cells, leading to widespread inflammatory responses. The disease can manifest in effusive (wet) or non-effusive (dry) forms. Effusive FIP produces fluid accumulation in body cavities such as the abdomen or thorax, while non-effusive FIP involves granulomas and inflammation in organs. Symptoms commonly include fever, weight loss, lethargy, and neurological signs, but these general symptoms can easily be mistaken for other illnesses.

Diagnosing FIP is notoriously difficult, partly because there is no single test that can confirm or rule out the illness with absolute certainty. The complexity stems from the coronavirus's ability to exist in benign forms in the feline population. Only a small percentage of infected cats develop the mutation that leads to FIP.

Laboratory Tests and Their Limitations

Multiple diagnostic tools exist to support FIP identification, but none are definitive. Common tests include:

Coronavirus antibody titers: Elevated titers indicate exposure, but do not distinguish between the harmless enteric coronavirus and the mutated FIP-causing form.

Polymerase Chain Reaction (PCR) assays: PCR can detect viral RNA in blood, effusions, or tissues. Sensitivity varies, and a negative result does not exclude disease since viral loads fluctuate.

Rivalta’s test: Used on abdominal or thoracic effusions, this test helps identify whether the fluid is suggestive of FIP, but false positives and negatives occur.

Immunohistochemistry: This test can detect viral proteins in affected tissues, offering strong evidence, but requires invasive sampling and specialized laboratory expertise.

Clinicians often rely on a combination of clinical signs, laboratory findings, and exclusion of other diseases. When test results are unclear or contradictory, uncertainty about diagnosis and subsequent treatment decisions persists.

Clinical Signs and the Challenge of Interpretation

Clinicians must integrate clinical observations with laboratory data. Signs of FIP can include persistent fever, poor appetite, jaundice, abdominal distension, difficulty breathing, ocular changes, and neurological deficits. Many chronic diseases mimic these signs. The wet form is somewhat easier to suspect, especially with classic yellow-tinged fluid in the abdomen or chest, high protein content, and low cellularity. However, in dry FIP cases, which lack effusion, the presentation can be more insidious and difficult to distinguish from other immunologic or neoplastic conditions.

Unclear results can truly complicate the situation. For example, a cat might have suggestive clinical signs, inconsistent laboratory values, and ambiguous imaging studies. Interpretation of these findings depends on comprehensive medical experience, thorough patient history, and an understanding of the disease’s variability.

Why Are Test Results Sometimes Unclear?

FIP’s pathogenesis contributes to its diagnostic uncertainty. Viral loads fluctuate due to the immune response, making detection by PCR inconsistent. Effusions may not always be present, particularly in non-effusive forms. Cell counts and protein levels in fluid analysis can overlap with other causes of inflammation. The diversity of coronavirus strains, genetic variability among cats, and the sometimes subclinical nature of the disease all add layers of complexity.

Certain laboratory markers such as elevated globulins, low albumin-to-globulin ratio, modest non-regenerative anemia, and lymphopenia can suggest FIP but none are pathognomonic. When test results are equivocal, veterinarians must use probability and clinical judgement.

The Role of Advanced Diagnostics

In recent years, molecular diagnostics have improved sensitivity and specificity. Immunohistochemistry and immunofluorescence for viral antigens in tissue biopsies have become more available. However, these methods still have limitations: the need for invasive sampling, cost, technical complexity, and occasional ambiguity in interpretation.

Genetic sequencing sometimes helps differentiate the FIP-causing mutated coronavirus, yet false negatives can still occur due to sampling errors or viral heterogeneity. Advanced imaging (ultrasound, CT scans) may reveal suggestive lesions but are rarely conclusive.

Some clinicians recommend diagnostic trials of anti-viral medications (such as GS-441524 or GC376), monitoring clinical response for confirmation, but this approach can be expensive and ethically challenging due to drug availability issues and legal restrictions in some countries.

Case Studies: When Test Results Don’t Tell the Whole Story

Patients sometimes present with classic clinical signs of FIP but have normal or ambiguous laboratory results. Consider a middle-aged rescue cat with persistent fever, marked abdominal distension, and lethargy. Fluid analysis may show borderline protein levels, Rivalta’s test results might be equivocal, and PCR on effusion fluid may return negative. Despite this, response to anti-viral therapy and progression of clinical signs can still confirm the diagnosis in retrospect.

Another scenario is a young cat adopted from a shelter, showing weight loss and jaundice. Lab work detects elevated globulins but negative coronavirus PCR. Exploratory surgery reveals granulomatous changes in the intestine; only a tissue biopsy with immunohistochemistry confirms presence of FIP antigen. Such cases underline the importance of not excluding FIP based solely on unclear test outcomes.

Diagnostic Algorithms: Weighing the Evidence

Veterinary internal medicine advocates for a holistic approach. Algorithms such as “diagnosis of exclusion” remain the gold standard when direct evidence is lacking. This method involves systematically ruling out other causes of acute or chronic inflammation (lymphoma, bacterial peritonitis, autoimmune diseases, toxoplasmosis, etc.) before settling on FIP as the most probable cause.

Confidence in diagnosis increases when multiple findings—history of exposure, age, breed predisposition (Birmans, Bengals, British Shorthairs are at higher risk), compatible clinical signs, and supportive lab data—converge. A lack of absolute confirmation does not mean FIP is absent; instead, probability-based medicine is often necessary when tests are unclear.

Ethical and Emotional Implications

The uncertainty in FIP diagnosis can be distressing for owners and clinicians. Early euthanasia or withholding treatment can be tragic in cases where diagnosis is in doubt. Conversely, treating for FIP inappropriately can cause unnecessary expenses and disappointment. Transparent communication, empathy, and shared decision-making are critical in managing such cases. Owners must understand the limits of current medical science and weigh the risks and benefits of interventions, particularly when test results are ambiguous.

Recent Advances and Future Directions

Ongoing research into new markers for FIP, improved PCR assays, and novel imaging techniques promises better diagnostic clarity. There is hope for a rapid point-of-care test that specifically identifies mutated coronavirus in cats, though such technologies are currently in developmental stages.

Immunotherapy and anti-viral compounds have begun to alter the prognosis for FIP, turning the disease from an automatic death sentence to a manageable condition when caught early. With these advances, the need for more precise diagnosis is increasingly urgent—especially given the cost and complexity of treatment.

Collaborations between researchers, practitioners, and patient advocates are vital to translate cutting-edge science into practical, reliable, and affordable diagnostic tools for the average veterinarian. For now, clinical acumen remains the most powerful weapon against FIP’s elusive nature.

Conclusion

Definitive diagnosis of FIP remains a clinical challenge, and unclear test results are not uncommon. While ongoing advances improve the veterinarian's ability to confirm or rule out the disease, the absence of clear test results does not exclude FIP. Decision-making must be based on a careful synthesis of history, clinical presentation, laboratory findings, and exclusion of other diseases. Owners and practitioners must recognize the limits of current diagnostics and embrace a holistic, evidence-based approach to treatment or supportive care. Informed decision-making, compassion, and ongoing research combine to offer the best hope for cats affected by this challenging illness.

References

1. Pedersen, N.C. (2014). An update on feline infectious peritonitis: Diagnostics and therapeutics. Veterinary Journal, 201(2), 133-141.

2. Addie, D.D., et al. (2009). Feline infectious peritonitis: ABCD guidelines on prevention and management. Journal of Feline Medicine and Surgery, 11(7), 594-604.

3. Felten, S., & Hartmann, K. (2019). Diagnosis of feline infectious peritonitis: A review of the current literature. Viruses, 11(11), 1068.

4. Kipar, A., & Meli, M.L. (2014). Feline infectious peritonitis: Still enigmatic after 50 years. Veterinary Pathology, 51(2), 505-526.

5. Stranieri, A., et al. (2018). Plasma proteome alteration in cats with effusive and non-effusive feline infectious peritonitis. Animals, 8(12), 228.

6. Tasker, S., & Baral, R. (2021). Diagnosing FIP: What is possible today? Veterinary Focus, 31(1), 24-34.

7. Barker, E.N., et al. (2017). Molecular detection of feline coronavirus in effusion samples from cats with suspected FIP. Veterinary Record, 180(17), 425.

8. Dempsey, S.M., & Ewing, P.J. (2011). Feline infectious peritonitis: Barriers to diagnosis. Comparative Immunology, Microbiology, and Infectious Diseases, 34(6), 491-495.

9. Izes, A.M., et al. (2020). Diagnosis of feline infectious peritonitis: a retrospective study of cases in South Africa. Journal of the South African Veterinary Association, 91, a1978.